Login
Contact Us
Media Kit
Weekly Round Up
May 7, 2025
•
13 min read
Private equity biotech deals dropped 62% since 2021—but the $4.91T market is heating up again. Here’s where smart capital is going next.
Long Form Article
May 6, 2025
4 min read
U.S. FinTech funding dropped to $9.6B in Q1 2025, down 54% YoY. Why investors are leaning into smaller, strategic deals—and what it means for the sector.
Macro View
3 min read
Economic Pulse Check: 2025 Set for Tepid Growth Amid Policy Shocks.
Research Deep Dive
14 min read
Biotech is set to triple in size by 2033. Explore the sectors, stages, and regions where capital is flowing—and what it means for investors.
Apr 30, 2025
It's Wednesday, and we're diving in the healthtech startups market. SEA deal value keeps growing, Yale looking for $6B secondary sale, and the correlative link between private credit and private equity funds.
How the Fed, Markets, and Investment Banks Strategize Around Interest Rates.
Survey
45.5% of PE sponsors say the U.S. is already in a recession. Our survey shows diverging views on the soft landing narrative heading into mid-2025.
US health tech deals peaked at 740 in 2021, down to 497 in 2024. AI now commands a growing share of funding as the sector enters maturity.
Apr 23, 2025
12 min read
Middle market PE deal value rose to $359B in 2024, showing stability after the 2021 peak. Carveouts and healthcare lead the way.
European PE fundraising hit $187B in 2024, but exit activity dropped to a five-year low. Sponsors brace for longer holds and limited distributions.
Monthly Deep Dive
22 min read
Middle-market PE deal value reached $359B in 2024, down from 2021 highs but signaling recovery. Sector trends, valuation data, and interest rate impacts inside.
Apr 16, 2025
After a 2021 high, Latin America PE is down to $1B in 2023. Investors weigh volatility vs. long-term upside across Brazil, Mexico, and Argentina.